SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-037205
Filing Date
2024-04-29
Accepted
2024-04-29 16:30:37
Documents
15
Period of Report
2024-04-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204901-8k_optimizer.htm   iXBRL 8-K 24740
2 PRESS RELEASE ea0204901-8kex99i_optimizer.htm EX-99.1 23254
6 GRAPHIC image_001.jpg GRAPHIC 5042
  Complete submission text file 0001213900-24-037205.txt   239025

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE oprx-20240426.xsd EX-101.SCH 3021
4 XBRL LABEL FILE oprx-20240426_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE oprx-20240426_pre.xml EX-101.PRE 22793
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0204901-8k_optimizer_htm.xml XML 3835
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 24891468
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)